Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
25 Januar 2024 - 12:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2024
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
25
January 2024 - Haleon to sell ChapStick
|
99.1
Haleon to sell ChapStick
25 January 2024: Haleon
plc, a global leader in consumer health, has entered into a binding
agreement for the sale of the ChapStick brand to Suave Brands
Company, a portfolio company of Yellow Wood
Partners.
Under the terms of the transaction, Haleon will receive pre-tax
cash proceeds of approximately $430 million, as well as a passive
minority interest in the Suave Brands Company. At the time of
entering into the binding agreement, this interest was valued at
approximately $80 million. Cash proceeds from the sale will be used
to pay down debt, underpinning our confidence to de-lever to net
debt/Adjusted EBITDA of below 3x during 2024.
ChapStick generated £112 million in revenue for the FY ended
31 December 2023.
The sale, subject to the satisfaction of customary closing
conditions, is expected to close in the second quarter of
2024.
Further detail on the transaction and its impact will be provided
within our FY 2023 Results announcement on 29 February
2024.
Brian McNamara, Chief Executive Officer, Haleon,
said: "Today's announcement is
consistent with Haleon being proactive in managing our portfolio,
and being rigorous and disciplined where there are opportunities
for divestment. While ChapStick is a great brand, much loved
by consumers around the world, it is not a core focus for Haleon.
Selling the brand allows us to simplify our business and pay down
debt more quickly. We're confident the brand will continue to
thrive under its new ownership."
Ends
---
Enquiries
|
Investors
|
Media
|
|
Sonya Ghobrial
|
+44 7392 784784
|
Nidaa Lone
|
+44 7841 400607
|
|
Rakesh Patel
|
+44 7552 484646
|
|
|
|
Emma White
|
+44 7792 750133
|
|
|
About ChapStick
ChapStick, the lip expert, makes it a priority to help people care
for their lips all year round. Originally created in the early
1880s, ChapStick is known today as America's favourite lip balm. As
part of Haleon, ChapStick offers a variety of products and fun
flavours that promote happier and healthier lips. For more
information, please visit www.chapstick.com.
About Haleon
Haleon
(LSE / NYSE: HLN) is a global leader in consumer health, with a
purpose to deliver better everyday health with humanity. Haleon's
product portfolio spans five major categories - Oral Health, Pain
Relief, Respiratory Health, Digestive Health and Other, and
Vitamins, Minerals and Supplements (VMS). Its long-standing brands
- such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin,
Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.
For more information, please visit
www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
Date:
January 25, 2024
|
By:
|
/s/
Amanda Mellor
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|
Haleon (NYSE:HLN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Haleon (NYSE:HLN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024
